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Abstract
Aim: The Cass Clinic is a student-run free clinic in Detroit, Michigan that treats chronic diseases including
hypertension (HTN), diabetes mellitus (DM), and obesity. Our study aims to quantify the effectiveness of our
clinic in managing chronic diseases.
Subject and methods: This study assessed selected health outcomes for 137 patients who visited our clinic
between September 1, 2017 and August 31, 2018 based on initial and most recent surrogate markers
including manual blood pressure, hemoglobin A1c (HbA1c), and body mass index (BMI) recorded in the
clinic’s medical record system dating back to 2012.
Results: Patients were divided into two groups: occasionally seen patients (OSP) and frequently seen
patients (FSP). FSP with HTN had systolic blood pressure (SBP) decreased by an average of 14.1 mmHg and
diastolic blood pressure (DBP) decreased by 9.8 mmHg, which were statistically associated with the number
of clinic visits. Additionally, all patients treated at Cass Clinic saw a decrease in their HbA1c and BMI. HbA1c
in OSP decreased by 0.50%. HbA1c in the FSP decreased by 1.7%. Patients with at least two recorded BMIs
(n=73) saw a decrease of 0.13 kg/m2.
Conclusion: The data from our analysis support that a student-run free clinic model like Cass Clinic provides
long-term value for patients who frequently utilize the clinic. These clinics also act as an important resource
for the community by making positive strides toward better health in multiple measurable outcomes,
including HTN and DM management.

Categories: Medical Education, Preventive Medicine, Public Health
Keywords: obesity, underserved, diabetes mellitus, hypertension, student-run free clinic

Introduction
This article was previously presented as a poster at the American Medical Association Research Symposium
on November 15, 2019. Hypertension (HTN), type II diabetes mellitus (DM), and obesity are highly prevalent
in the U.S. and greatly contribute to morbidity and mortality. Data collected by the Center for Disease
Control and Prevention (CDC) revealed that approximately 75 million U.S. adults between 2011 and 2012
had HTN, which equates to one in every three adults [1]. In 2015, more than 100 million U.S. adults were
living with DM or prediabetes [2]. In 2015-2016, obesity, which affected 93.3 million U.S. adults, was
prevalent in 39.8% of the population [3]. Individuals with these chronic diseases are at an increased risk for
heart disease and stroke, which are the leading causes of death in the U.S. The estimated combined medical
costs of these conditions result in hundreds of billions of dollars each year. These diseases place a
significant strain on our economy and the overall health of our society.
Treating these chronic conditions is important in reducing this burden. However, whether a patient can
achieve and maintain disease control is dependent on several socioeconomic factors, including their access
to affordable healthcare. The U.S. had 13.7% uninsured and 29% underinsured adults in the fourth quarter of
2018, both at their highest level since the first quarter of 2014 [4,5]. Many uninsured and underinsured
patients rely on safety-net hospitals, non-profit or faith-based organizations, and free clinics for their
medical needs. In 2018, free health care was provided to over 34,044 uninsured patients in Michigan via
various free clinics, including student-run free clinics [6]. By managing HTN, DM, and obesity in studentrun free clinics, such as the Cass Clinic, there is potential to dramatically improve the health of uninsured
and underinsured patients.
Cass Clinic is a student-run free clinic organization operating two sites in Detroit. It has served
underinsured and uninsured patients since the late 1970s. The clinic primarily treats chronic diseases,
including HTN, DM, and obesity. During a typical patient visit, medical students conduct an interview,
perform a focused physical exam, and, when appropriate, obtain certain laboratory tests, including
glycosylated hemoglobin A1c (HbA1c), lipid panel, and blood glucose readings. The student team then
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presents the case to an attending physician and, together, they come up with a treatment plan, which
includes medications, lifestyle modifications, patient education, and referrals.
All Cass Clinic patients have their vital signs, height, and weight checked at every visit. BMI calculation
allows for proper nutrition and exercise counseling. Cass Clinic patients with HTN have their blood pressure
manually checked by either a medical student or a volunteer nurse practitioner. Medications are then
adjusted accordingly, and they are subsequently given a one-month refill on their antihypertensive
medications. During the visit, they will also receive counseling on improving their nutrition, smoking
cessation, and the importance of exercise. Cass Clinic patients with DM are provided glucometers and asked
to measure their blood glucose at least twice a day, which is then reviewed at each visit. A fasting or random
glucose test is checked, and patients receive a one-month refill on their insulin, needles, syringes, and
glucometer test strips, in addition to access to a diabetes nurse educator. Cass Clinic also hosts several other
student organizations, including FreshRx, which provides patients with a prescription to eat more fruits and
vegetables, which can be filled at partnering farm stands or markets, and Sight Savers, which provides free
eye exams, glaucoma screenings, and prescription glasses. In addition to chronic disease management,
patients receive care for acute illnesses, allergies, and asthma. In 2017, Cass Clinic facilitated over 650
patient encounters provided by over 1,688 volunteer hours from undergraduate, medical, and other
healthcare-associated graduate students.
Nearly, 38% of Detroit’s approximate 670,000 residents lived below the poverty line in 2017, with 13.8% of
the population under 65 being uninsured [7]. It is well documented that health outcomes and chronic
disease management are negatively affected by poverty and lack of insurance coverage, making our clinic an
important resource for patients who would otherwise go untreated. While providing free medical care for this
population seems valuable, the impact of Cass Clinic on chronic disease management has never been
formally quantified. There have been several studies showcasing that HTN management in student-run free
clinics is on par with national data [8,9]. However, limited research exists concerning the treatment and
outcomes of DM in these clinics, and studies regarding counseling and improvements among the obese
populations are rare. Our methodology is unique in that we were able to individually assess the HTN, DM,
and obesity management of Cass Clinic patients.
The study aims to confirm whether Cass Clinic improved selected health outcomes for its patients with
chronic diseases including HTN, DM, and overweight/obesity based on surrogate markers including manual
blood pressure, HbA1c, and body mass index (BMI), respectively, that have been recorded in the clinic’s
electronic medical record (EMR) system. We also looked for differences in outcomes based on visit
frequency; that is, whether a patient was a frequently seen patient (FSP) or an occasionally seen patient
(OSP) in the clinic. This study will help Cass Clinic and other student-run free clinics better understand the
Detroit population that utilizes our clinics and how to best provide care to our patients.

Materials And Methods
Cass Clinic has student teams document all patient encounters in an EMR system that has been in use since
2012, PracticeFusion©, and patient charts are subsequently reviewed by the clinic EMR coordinator and
signed as a quality control measure. This study was conducted by the Cass Clinic coordinators. There were no
exclusion criteria for this study. Patients were included if they had been treated in our clinic between
September 1, 2017 and August 31, 2018. This time period was chosen as it was before the COVID-19
pandemic caused a temporary shutdown of the clinic. After selecting patients, patient data including patient
date of birth, age, gender at birth, ethnicity/race, current or history of smoking, diagnosis of DM or HTN,
first encounter date, most recent encounter date, medication for DM or HTN at any time as a Cass Clinic
patient, the total number of days between first and most recent encounters, the total number of visits
documented in the EMR, first and most recent documented blood pressure, first and most recent
documented HbA1c, and first and most recent documented BMI were collected via chart review (Table 1).
These variables were all chosen as they are consistently documented in each patient's chart and can act as
valid surrogate markers for the management of chronic diseases. The Cass Clinic EMR does not have a
designated area for HbA1c documentation. Instead, the result of an HbA1c lab test is written in the
encounter note. The patient’s first encounter date may have occurred as early as 2012, when the Cass Clinic
transitioned to the current EMR system from paper-based documentation. Data from 2012 to the end of the
study period on August 31, 2018 was included. Patients who were only seen once were excluded.
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Variable

Data collected

Date of birth

Month/day/year (age)

Gender at birth

Male or female

Ethnicity/race

African American, White, Hispanic/Latino, Native American, Asian American, other

Smoker at anytime

Yes or no

Type 2 DM diagnosis

Yes or no

HTN diagnosis

Yes or no

First encounter date

Month/day/year

Most recent encounter date

Month/day/year

At any time DM medication

Yes or No

At any time HTN medication

Yes or No

Total number of days between first encounter and last encounter

Total number of days

Total number of visits

Total number of visits

First documented blood pressure

Systolic BP/diastolic BP

First documented HbA1c

HbA1c number

First documented BMI

BMI number

Most recent documented blood pressure

Systolic BP/diastolic BP

Most recent documented HbA1c

HbA1c number

Most recent documented BMI

BMI number

TABLE 1: Variables and data collected
DM: diabetes mellitus, HTN: hypertension, HbA1c: hemoglobin A1c, BMI: body mass index

Patients were considered to have HTN if they reported a prior physician diagnosis of HTN, previous use of
HTN medication, or if they had two separate readings of either systolic blood pressure (SBP) >140 mmHg or
diastolic blood pressure (DBP) >90 mmHg, which is consistent with the Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines in 2012,
when our EMR was first introduced and many of our frequently seen patients’ first blood pressure readings
were recorded. Similarly, patients were considered to have DM if they reported a prior physician diagnosis of
DM, previous use of DM medication, or HbA1c >6.5%. A unique patient identification number identified each
patient, and all information was input into an Excel spreadsheet (Microsoft Excel, Microsoft® Corp.,
Redmond, WA). The difference (referred to as Delta in the results section) in the patient’s initial and most
recent measurements for systolic blood pressure and diastolic blood pressure, BMI, and HbA1c were then
calculated to determine the change in each surrogate marker as a reflection of chronic disease management.
Initial screening found 252 patients who were seen during our study period. Patients who were only seen
once were excluded from the analysis (n=115). Charts were reviewed for the remaining 137 patients. The
patients were then analyzed based on overall clinic use rate, diagnosis of HTN, and diagnosis of DM. Based
on the overall clinic use rate, they were divided into "OSP" and "FSP" based on how many total visits to the
clinic they made. The median number of visits for all patients included in the analysis was nine visits. This
served as our cut-off, establishing OSP as those with a total of two to nine visits and FSP as those who have
more than nine visits. Patients were also separated by a diagnosis of either HTN or DM and again stratified
by utilization of the clinic. There were 110 patients diagnosed with HTN. The median visit count was 15 for
patients diagnosed with HTN and this served as our cut-off with OSP having a total of two to 15 visits and
FSP having more than 15 visits. There were 43 patients diagnosed with DM. The median visit count was 13
for patients diagnosed with DM, and this served as our cut-off, with OSP having a total of two to 13 visits
and FSP having more than 13 visits.
Analysis was performed with statistical analysis systems (SAS) and included the use of a t-test, Wilcoxon
Rank Sum t-test approximation, Chi-Squared test, and Fisher’s Exact test to determine the statistical
significance of all data points. Statistical significance was set at p<0.05.

Results
OSP demographics include an average age of 49.4 years old, 49.3% female, 50.7% male, 61.8% current or
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have a history of smoking, 26.1% diagnosed with DM, 63.8% diagnosed with HTN, 23.2% treated with DM
medication, and 58% treated with an antihypertensive (Table 2). On average, an OSP visited the clinic four
times (Table 3). Demographics of FSP include average age of 60.1 years old, 33.8% female and 66.2% male,
52.9% are current or have a history of smoking, 36.8% were diagnosed with DM, 97.1% with HTN, 35.3% with
DM medication, and 97.1% were treated with an antihypertensive (Table 2). On average, an FSP visited the
clinic 31.2 times, and an OSP visited an average of 4 times (Table 3). There was a statistically significant
difference between the number of OSP and FSP with HTN (p<0.0001) and treated with anti-hypertensives
(p<0.0001). There was no statistically significant difference between FSP and OSP with DM (p=0.1781) or
taking medication for DM (p=0.1192).

Variable

All patients N(N%)

OSP* N(N%)

FSP** N(N%)

Number of patients

137

69

68

Age

54.7 + 12.56

49.4 + 13.66

60.1 + 8.51

Sex

p-value

<0.0001
0.0666

Female

57 (41.6)

34 (49.3)

23 (33.8)

Male

80 (58.4)

35 (50.7)

45 (66.2)

Race

0.6795

African American

87 (87.9)

38 (86.4)

49 (89.1)

White

12 (12.1)

6 (13.6)

6 (10.9)

Ever smoker

0.2982

Yes

78 (57.4)

42 (61.8)

36 (52.9)

No

58 (42.6)

26 (38.2)

32 (47.1)

Diabetic

0.1781

Yes

43 (31.4)

18 (26.1)

25 (36.8)

No

94 (68.6)

51 (73.9)

43 (63.2)

Hypertension

<0.0001

Yes

110 (80.3)

44 (63.8)

66 (97.1)

No

27 (19.7)

25 (36.2)

2 (2.9)

Patient takes DM medication

0.1192

Yes

40 (29.2)

16 (23.2)

24 (25.3)

No

97 (70.8)

53 (76.8)

44 (64.7)

Patient takes HTN medication

<0.0001

Yes

106 (77.4)

40 (58)

66 (97.1)

No

31 (21.6)

29 (42)

2 (2.9)

TABLE 2: Summary of Cass Clinic patients
*2-9 visits; **>9 visits; p<0.05 is statistically significant
OSP: occasionally seen patient, FSP: frequently seen patient, DM: diabetes mellitus, HTN: hypertension

2022 Beydoun et al. Cureus 14(7): e26701. DOI 10.7759/cureus.26701

4 of 10

All patients

All patient’s mean + SD

OSP* N

OSP* mean + SD

FSP** N

FSP** mean +SD

p-value

Initial visit SBP (mmHg)

130

147.3 + 19.48

64

141.5 + 19.76

66

152.8 + 17.64

0.0008

Initial visit DBP (mmHg)

129

90.9 + 13.11

64

87.2 + 12.55

65

94.5 + 12.71

0.0017

Initial visit BMI

84

31.7 + 7.56

49

30.68 + 7.48

35

33.14 + 7.54

0.1405

Initial A1c

32

9.3 + 2.71

10

9.12 + 3.41

22

9.38 + 2.41

0.4816

Most recent visit SBP (mmHg)

134

135.2 + 16.4

66

135.9 + 15.93

68

134.5 + 16.93

0.5983

Most recent visit DBP (mmHg)

134

82.3 + 10.71

66

84 + 11.04

68

80.7 + 10.2

0.0816

Most recent visit BMI

109

31.25 + 7.346

51

31.5 + 7.65

58

31.03 + 7.13

0.8701

Most recent A1c

25

7.65 + 1.90

5

6.84 + 0.063

20

7.86 + 2.07

0.5681

Visit count

137

17.5 + 18.27

69

4 + 2.32

68

31.2 + 17.11

<0.0001

SBP Delta

128

−12.1 + 20.05

62

−5.5 + 19.45

66

−18.3 + 18.71

0.0002

DBP Delta

127

−8.7 + 14.7

62

−3 + 13.57

65

−14.2 + 13.71

<0.0001

A1c Delta

25

−1.4 + 1.35

5

−0.5 + 1.11

20

−1.7 + 1.32

0.0794

BMI Delta

73

−0.13 + 2.084

42

−0.18 + 2.19

31

−0.06 + 1.967

0.4637

TABLE 3: Statistical summary for all clinic patients by the use rate
*2-9 visits; **>9 visits; p<0.05 is statistically significant
SBP: systolic blood pressure, DBP: diastolic blood pressure, BMI: body mass index, A1c: hemoglobin A1c

Among all patients, SBP decreased by an average of 12.1 mmHg (95% CI [−15.57, −8.63]) and DBP decreased
by 8.7 mmHg (95% CI [−11.25, −6.15]) between the first and most recent visit. OSP had an average SBP
decrease of 5.5 mmHg (95% CI [−10.34, −0.659]) and a DBP of 3 mmHg (95% CI [−6.38, 0.38]). FSP had an
average SBP decrease of 18.3 mmHg (95% CI [−22.81, −13.79]) and a DBP decrease of 14.2 mmHg (95% CI
[−17.53, −10.87]). There was a statistically significant difference in the decrease in SBP and DBP between
OSP and FSP (p<0.0001 and p=0.0002, respectively) (Table 3). There was no statistically significant
difference in decreased HbA1c (p=0.0794). Patients with at least two recorded BMIs (n=73) saw a decrease of
0.13 kg/m2 (95% CI [−0.608, 0.348]). OSP had a decrease of 0.18kg/m 2 (n=42) (95% CI [−0.842, 0.482]) and FSP
had a decrease of 0.06kg/m2 (n=31) (95% CI [−0.752, 0.632]). The average BMI change stratified by OSP and
FSP was not statistically significant (p=0.4637) (Table 3).
Patients were separated by a diagnosis of either HTN or DM and then further stratified by utilization of the
clinic. The median visit count was 15 for patients diagnosed with HTN; the median visit count was 13 for
patients diagnosed with DM; and the median visit count was 17.5 for patients diagnosed with DM and HTN.
Disease-specific median visit counts were used to further analyze disease modification for patients with
HTN or DM by once again classifying patients as OSP or FSP.
Overall, patients diagnosed with HTN (n=110) had SBP decreased by 14.1 mmHg (95% CI [−17.95, −10.26])
and DBP decreased by 9.8 mmHg (95% CI [−12.67, −6.94]). OSP (two to 15 visits) with HTN had an average
SBP decrease of 10.2 mmHg (95% CI [−14.24, −6.16]) and DBP of 5.3 mmHg (95% CI [−8.13, −2.47]), while
FSP (>15 visits) with HTN had an average SBP decrease of 18.2 mmHg (95% CI [−21.70, −14.70]) and DBP of
14.8 mmHg (95% CI [−17.42, −12.18]). The difference in the decrease in SBP and DBP in OSP and FSP with
HTN was statistically significant (p=0.0426 and p=0.0010, respectively) (Table 4). Furthermore, the average
age of FSPs diagnosed with HTN was 60.4 years old; for OSPs, the average age was 55.2 years old (p=0.0025)
(Table 4).
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All patients N

All patients mean + SD

OSP* N

OSP* mean + SD

FSP** N

FSP** mean +SD

p-value

Initial visit SBP (mmHg)

107

151.5 + 17.97

56

149.5 + 19.01

51

153.7 + 16.68

0.2368

Initial visit DBP (mmHg)

106

93.2 + 12.67

56

91.1 + 11.91

50

95.6+ 13.19

0.0990

Initial visit BMI

68

32.94 + 7.34

41

33.29 + 7.40

27

32.4 + 7.35

0.7174

Initial A1c

28

9.1 + 2.54

11

8.41 + 2.93

17

9.55 + 2.23

0.1264

Most recent visit SBP (mmHg)

109

137.6 + 16.37

56

139.7 + 17.97

53

135.5 + 14.34

0.0633

Most recent visit DBP (mmHg)

109

83.5 + 10.73

56

85.6 + 11.86

53

81.2 + 8.98

0.0256

Most recent visit BMI

88

32.17 + 7.15

44

33.24 + 7.03

44

31.11 + 7.19

0.2248

Most recent A1c

22

7.54 + 1.76

7

6.56 + 0.45

15

7.99 + 1.96

0.1116

Visit count

110

20.2 + 18.51

57

6 + 4.14

53

35.4 + 15.58

<0.0001

SBP Delta

106

−14.1 + 20.2

55

−10.2 + 21.21

51

-18.2 + 18.38

0.0426

DBP Delta

105

−9.8 + 14.98

55

−5.3 + 14.78

50

−14.8 + 13.69

0.0010

A1c Delta

22

−1.5 + 1.33

7

−0.9 + 0.98

15

−1.8 + 1.39

0.1299

BMI Delta

59

−0.08 + 2.21

35

−0.13 + 2.33

24

0.01 + 2.07

0.2336

TABLE 4: Statistical summary for Cass Clinic patients with diagnosis of hypertension
*2-15 visits; **>15 visits; p<0.05 is statistically significant
SBP: systolic blood pressure, DBP: diastolic blood pressure, BMI: body mass index, A1c: hemoglobin A1c

There were 43 patients with documented DM. Only 25 had at least two HbA1c recordings for analysis. Among
those 25 patients, there was a decrease of 1.4% in HbA1c. OSP (two to 13 visits) with DM had an HbA1c
decrease of 0.50% (n=5) and FSP (>13 visits) with DM had a decrease of 1.7% (n=20). The average HbA1c
decrease between OSP and FSP was not statistically significant (p=0.1733) (Table 5). However, the SBP
decrease among DM patients was significant. Among all patients with DM, SBP decreased by 12.7 mmHg
(95% CI [−19.21, −6.19]) and DBP decreased by 6.4 mmHg (95% CI [−11.12, −1.68]). OSP with DM had an
average SBP decrease of 5.2 mmHg (95% CI [−14.54, 4.14]) and DBP of 4 mmHg (95% CI [−11.77, 3.77]), while
FSP with DM had an average SBP decrease of 20.9 mmHg (95% CI [−28.65, −13.15]) and DBP of 9.1 mmHg
(95% CI [−14.11, −4.09]). The difference in the decrease in SBP between OSP and FSP was statistically
significant (p=0.0162), but was not for DBP (p=0.2867) (Table 5). The difference in BMI between OSP with
DM, which decreased 0.73 kg/m2, and FSP with DM, which decreased by 0.67 kg/m 2 was not statistically
significant (p=0.4285) (Table 5).
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All patients N

All patients mean + SD

OSP* N

OSP* mean + SD

FSP** N

FSP** Mean +SD

p-value

Initial visit SBP (mmHg)

42

147.8 + 20.44

22

143.3 + 20.88

20

152.7 + 19.29

0.1415

Initial visit DBP (mmHg)

42

88.2 + 11.09

22

87.3 + 13.72

20

89.3 + 7.43

0.5607

Initial visit BMI

29

34.42 + 8.29

18

35.38 + 8.89

11

32.85 + 7.32

0.4364

Initial A1c

30

8.99 + 2.71

12

8.42 + 2.78

18

9.37 + 2.29

0.1604

Most recent visit SBP (mmHg)

43

135 + 15.72

22

138.1 + 14.64

21

131.7 + 16.46

0.1803

Most recent visit DBP (mmHg)

43

81.8 + 9.97

22

83.3 + 11.23

21

80.2 + 8.46

0.3244

Most recent visit BMI

35

32.97 + 8.03

17

16.9 + 2.61

18

31.18 + 7.81

0.1785

Most recent A1c

24

7.47 + 1.71

8

6.68 + 0.534

16

7.87 + 1.96

0.2434

Visit count

43

19.5 + 17.25

22

5.2 + 3.62

21

34.5 + 12.99

<0.0001>

SBP Delta

42

−12.7 + 21.53

22

−5.2 + 22.34

20

−20.9 +17.68

0.0162

DBP Delta

42

−6.4 + 15.62

22

−4 + 18.59

20

−9.1 + 11.43

0.2867

A1c Delta

24

−1.4 + 1.37

8

−0.9 + 1.22

16

−1.7 + 1.4

0.1733

BMI Delta

26

−0.14 + 2.278

15

−0.73 + 1.995

11

−0.67 + 2.48

0.4285

TABLE 5: Statistical summary for Cass Clinic patients with diagnosis of type II diabetes mellitus
*2-15 visits; **>15 visits; p<0.05 is statistically significant
SBP: systolic blood pressure, DBP: diastolic blood pressure, BMI: body mass index, A1c: hemoglobin A1c

Discussion
Cass Clinic primarily treats patients with chronic diseases, including HTN, DM, and obesity. A majority of
patients in our study had been diagnosed with HTN, DM, or both. Our study demonstrates that patients
overall saw a decrease in their systolic and diastolic blood pressures. Among all patients, SBP decreased by
an average of 12.1 mmHg and DBP decreased by 8.7 mmHg between the first and most recent visit. This
finding is clinically relevant as studies have shown a 5 mmHg reduction in systolic blood pressure reduces
the risk of major cardiovascular events by about 10%, irrespective of previous diagnoses of cardiovascular
disease and even at normal or high-normal blood pressure values [10]. Patients who were seen more
frequently had a greater reduction in both SBP and DBP, compared with those less frequently seen in the
clinic. This finding was confirmed when patients with a formal diagnosis of HTN were analyzed separately.
The more significant decrease in blood pressure in FSP may be attributed to a number of factors. First, the
average age of FSP was higher than OSP by 10.7 years overall, and by 5.2 years in those diagnosed with
hypertension. Older age is often associated with more advanced stages of chronic disease and thus may leave
more room for improvement. For example, the average SBP and DBP measured at the FSPs’ initial visits were
higher than the OSPs’ in our patients overall; however, this difference did not hold true for patients with
HTN. It is also possible that those who frequent the clinic more often may inherently be more motivated to
improve their health outcomes and be more adherent to their medications and lifestyle adjustments.
Patients with DM had an overall decrease in their initial versus final HbA1c values regardless of the visit
frequency. While there was no statistically significant difference in the decrease in average HbA1c between
FSP and OSP, a clinically significant improvement was present in both groups. OSP had an average decrease
in HbA1c by 0.50% and FSP by 1.7%. Based on the ADA and National Institute for Health and Clinical
Excellence treatment guidelines, 0.5% HbA1c is considered a clinically significant change [11,12]. It has been
reported that an HbA1c decrease of 1% is associated with an 18% decrease in cardiovascular risk and a 37%
reduction in microvascular complications [13,14]. The lack of statistical significance may be due to the
smaller sample size (n=25) of patients who had two recorded HbA1c values in their records. Cass Clinic’s
EMR does not contain a designated section for HbA1c to be charted (unlike BP, HR, etc.), and volunteers are
often asked to enter the data into the patient’s note. It is likely that not all values were recorded, given the
relatively higher number of patients diagnosed with DM (n=43).
It is also worth noting that in those diagnosed with DM, FSP saw a statistically significant decrease in SBP
compared to OSP. However, OSP still had a clinically significant decrease of 5.2 mmHg in SBP. Diabetic
patients with uncontrolled HTN have a substantially higher risk of developing coronary artery disease,
retinopathy, stroke, and renal disease, compared with those only diagnosed with diabetes [15]. Lowering BP
in diabetic patients resulted in a decreased risk of cardiovascular events, coronary heart disease, stroke,
albuminuria, and retinopathy, ultimately improving the mortality of these patients [16,17].
The Cass clinic primarily manages obesity through counseling and its partnership with FreshRx and local
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food banks. While there was no significant difference in BMI between FSP and OSP, all patients did have an
average decrease of 0.13 kg/m2 in their BMI. Notably, patients with DM had the greatest decrease in BMI.
This may be attributed to the rigorous nutrition counseling and diabetes management education provided by
the volunteer diabetic nurse practitioner in the clinic and the medical students. Proper nutrition therapy is
essential to the management of DM and HTN. Cass Clinic’s partnership with FreshRx further reiterates this
point by providing patients with the opportunity to obtain fresh produce and participate in cooking classes.
The lack of statistical significance in regards to BMI may be twofold-for some patients, the goal may not be
weight loss but weight maintenance and improving nutrition overall by choosing healthier foods.
Additionally, BMI is based on weight, which can be impacted by the clothes a patient is wearing. It is
possible that weight was not accurately measured and recorded, which can impact the calculation of BMI.
Moving forward, the clinic would benefit from a standardized way to measure weight and more close followup of patients who are obese. Furthermore, partnering with other community organizations to promote
exercise and healthy eating may also help improve the clinic’s obesity management.
Controlling BP in hypertensive patients (maintaining <130/80 mmHg) continues to challenge the U.S.
healthcare system for decades despite effective treatments and national campaigns prioritizing BP control in
those with HTN and DM [18]. The biennial National Health and Nutrition Examination Survey (NHANES)
demonstrated no significant change in mean SBP or DBP among hypertensive patients receiving
pharmacologic intervention between 1999 and 2016 [19]. Overall, NHANES shows that over a four-year
period from 2013 to 2016, the average age-adjusted hypertensive patient saw average SBP and DBP increase
[20]. These findings contrast with those of Cass Clinic’s over a similar time period, where hypertensive
patients had an initial recorded average BP of 151.5/93.2 mmHg, with a 12.1 mmHg reduction in SBP and an
8.7 mmHg reduction in DBP. Additionally, the average hypertensive FSP, where the greatest improvement in
BP was seen, was 60.1 years old and African American. These demographics nationally are challenging to
treat (i.e., African American, age ≥ 60), since they have shown no consistent improvement in BP control
based on NHANES data from 1999 to 2016 [19]. Additional relevant demographic data including
homelessness, poverty, no primary care provider, and uninsured are not actively tracked by Cass Clinic, but
are demographics our clinic is designed to treat. These serve as additional barriers that often limit
adherence and BP management and are hurdles our patients manage to overcome.
With a limited data set, we believe the clinic has demonstrated a meaningful improvement in BP
management among patients with various social barriers to health, such as lack of insurance and
transportation. We believe the clinic’s success in lowering both SBP and DBP and the statistical association
with the number of clinic visits is largely due to the clinic’s holistic approach, which promotes treatment
compliance by providing close follow-up and a multitude of services. Patients receive not only care for their
chronic diseases but can have eye exams, referrals to psychiatric and dental services, free clothing and
toiletries, and care for any other acute issues during the visit. The services and medications provided by Cass
Clinic may have a direct relationship with decreased BP values in patients who were more frequently seen.
Frequently seen patients may have their BP monitored more regularly by the clinic, allowing for more
frequent medication adjustments and better control of the disease. In those not formally diagnosed with
HTN but found to have elevated BPs in the clinic, effective counseling may have affected the BP outcomes
seen in our study.
National data from NHANES show that even with these medications being widely available and effective,
national BP target goals continue to fall short. This has been largely attributed to poor medication
adherence [19]. Improved adherence in the ambulatory setting has most consistently been associated with
simplified dosing regimens, while other interventions such as motivational strategies and complex
interventions including home visits, work-site care, and telecommunication reminders have shown varied
success [21]. Though it is unclear why Cass Clinic is demonstrating success in lowering BP in both OSP and
FSP hypertensive patients, it is likely a combination of patient education, fewer available medication
options, possibly translating to simpler regimens, and ease of access with a clinic model that is free for the
patient and does not require insurance or appointments. Improved access may be contributing to increased
patient clinic visits, which has been shown in national data to translate to a higher likelihood of BP control
in hypertensive patients [20]. Future studies should be pursued to better elucidate the cause of these
meaningful outcomes at the Cass Clinic.
This research was limited by the short study time period and the fact that we considered only two values for
each surrogate marker in assessing the management of chronic diseases. Additionally, missing HbA1c
recordings for DM patients limited our ability to make stronger conclusions about our data. At Cass Clinic, a
standardized pre-volunteering meeting to train students on the EMR would likely help to alleviate
inconsistent recording of data. Given our lack of statistically significant findings on BMI changes between
the FSP and OSPs, additional training on effective counseling techniques regarding diet, exercise, and other
lifestyle changes would not only be beneficial in lowering BMI but also BP and HbA1c. A controlled study
comparing different counseling methods may be conducted to look for improvement in our surrogate
markers. Finally, we believe that administering satisfaction surveys to all patients would help to improve the
clinic experience, which may in turn be associated with better health outcomes for patients.
These encouraging findings support the notion that a student-run free clinic like Cass Clinic provides
meaningful value for patients locally and serves as a community resource for managing BP, DM, and obesity.
Literature exists on the importance of creating continuity of care for managing chronic disease states like
HTN, especially the need for improved collaboration on the transition of care from emergency departments
(ED) to primary care providers [22].
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Conclusions
Student-run free clinics like Cass Clinic may play a meaningful role, especially since Cass Clinic’s model is
targeted toward patients who are uninsured, without a primary care physician, and may not be able to afford
their medication. The population most likely to have undiagnosed or uncontrolled HTN and be reliant on ED
resources for chronic disease management may be the same population targeted by a student-run free clinic.
Moving forward, a retrospective cohort study of Cass Clinic patients and their utilization of ED resources for
chronic disease management may provide further insight into this theory. Additionally, the proximity of
Cass Clinic to a major hospital system, its accommodation of walk-ins, and its referral system to higher
levels of care may further support the clinic’s role in this continuity of care.

Additional Information
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study. Wayne State University
issued approval 121717MP2X. The study was given a concurrence of exemption. Animal subjects: All
authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In
compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services
info: All authors have declared that no financial support was received from any organization for the
submitted work. Financial relationships: All authors have declared that they have no financial
relationships at present or within the previous three years with any organizations that might have an
interest in the submitted work. Other relationships: All authors have declared that there are no other
relationships or activities that could appear to have influenced the submitted work.

Acknowledgements
We thank Cass Community Social Services for providing a space and being a partner to Cass Clinic and
Wayne State University School of Medicine for their continued support of the Cass Clinic.

References
1.
2.
3.
4.
5.

6.

7.
8.
9.

10.

11.
12.

13.

14.

15.
16.
17.
18.
19.

20.

CDC: High blood pressure fact sheet . (2019). Accessed: January 1, 2020:
https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm.
New CDC report: more than 100 million Americans have diabetes or prediabetes . (2016). Accessed: January
1, 2020: https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html.
Adult obesity facts | Overweight and Obesity | CDC . (2019). Accessed: January 31, 2020:
https://www.cdc.gov/obesity/data/adult.html.
U.S. uninsured rate rises to four-year high . (2019). Accessed: January 31, 2020:
https://news.gallup.com/poll/246134/uninsured-rate-rises-four-year-high.aspx.
Underinsured rate rose from 2014-2018, with greatest growth among people in employer health plans.
Commonwealth Fund. (2019). Accessed: January 31, 2022: https://www.commonwealthfund.org/pressrelease/2019/underinsured-rate-rose-2014-2018-greatest-growth-among-people-emp....
Final free clinic report - State of Michigan. Michigan Department of Health and Human Services . (2018).
Accessed: January 31, 2022:
https://www.michigan.gov/documents/mdhhs/FINAL_Free_Clinic_Report_FY2018_AM_Edits_w_correct_phone_number_660825_7.pdf
U.S. Census Bureau QuickFacts: Detroit City, Michigan . (2019). Accessed: January 31, 2020:
https://www.census.gov/quickfacts/fact/table/detroitcitymichigan.
Zucker J, Gillen J, Ackrivo J, Schroeder R, Keller S: Hypertension management in a student-run free clinic:
meeting national standards?. Acad Med. 2011, 86:239-45. 10.1097/ACM.0b013e31820465e0
Wahle B, Meyer K, Faller M, Kochhar K, Sevilla J: Assessment of hypertension management and outcomes at
an Indianapolis student-run free clinic. J Health Care Poor Underserved. 2017, 28:694-706.
10.1353/hpu.2017.0068
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease
across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021,
397:1625-36. 10.1016/S0140-6736(21)00590-0
Standards of medical care in diabetes--2010. Diabetes Care. 2010, 33 Suppl 1:S11-61. 10.2337/dc10-S011
National Institute for Health and Clinical Excellence: Newer Agents for Blood Glucose Control in Type 2
Diabetes. Centre for Clinical Practice at NICE, London; 2009.
https://www.ncbi.nlm.nih.gov/books/NBK61842/.
Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis:
glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004, 141:421-31.
10.7326/0003-4819-141-6-200409210-00007
Stratton IM, Adler AI, Neil HA, et al.: Association of glycaemia with macrovascular and microvascular
complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321:405-12.
10.1136/bmj.321.7258.405
El-Atat F, McFarlane SI, Sowers JR: Diabetes, hypertension, and cardiovascular derangements:
pathophysiology and management. Curr Hypertens Rep. 2004, 6:215-23. 10.1007/s11906-004-0072-y
Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A: Blood pressure lowering in type 2 diabetes: a
systematic review and meta-analysis. JAMA. 2015, 313:603-15. 10.1001/jama.2014.18574
de Boer IH, Bangalore S, Benetos A, et al.: Diabetes and hypertension: a position statement by the American
Diabetes Association. Diabetes Care. 2017, 40:1273-84. 10.2337/dci17-0026
Heart disease and stroke | Healthy People . (2020). Accessed: August 25, 2019:
https://www.healthypeople.gov/2020/topics-objectives/topic/heart-disease-and-stroke/objectives.
Dorans KS, Mills KT, Liu Y, He J: Trends in prevalence and control of hypertension according to the 2017
American College of Cardiology/American Heart Association (ACC/AHA) Guideline. J Am Heart Assoc. 2018,
7:10.1161/JAHA.118.008888
Ostchega Y, Zhang G, Hughes JP, Nwankwo T: Factors associated with hypertension control in US adults

2022 Beydoun et al. Cureus 14(7): e26701. DOI 10.7759/cureus.26701

9 of 10

21.

22.

using 2017 ACC/AHA guidelines: National Health and Nutrition Examination Survey 1999-2016. Am J
Hypertens. 2018, 31:886-94. 10.1093/ajh/hpy047
Schroeder K, Fahey T, Ebrahim S: How can we improve adherence to blood pressure-lowering medication in
ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004, 164:722-32.
10.1001/archinte.164.7.722
Brody A, Janke A, Sharma V, Levy P: Public health, hypertension, and the emergency department . Curr
Hypertens Rep. 2016, 18:50. 10.1007/s11906-016-0654-5

2022 Beydoun et al. Cureus 14(7): e26701. DOI 10.7759/cureus.26701

10 of 10

